trial · primary record
Ibrutinib
Chronic Lymphocytic Leukemia
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 465 |
| Primary completion | 2026-12-29 |
| Primary endpoint | Progression-free Survival (PFS) |
| Registry ID | NCT03737981 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:12.204Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03737981
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.